Tunisian Lung Cancer Study

Not yet recruiting

• Conditions: Pulmonary Cancer

• Registration Number: NCT06934499
• Lead Sponsor: Dacima Consulting

Brief Summary

This is a prospective, multicenter, observational, national study. Eligible patients will be recruited consecutively among subjects with proven lung cancer, including any disease stage withclinical, therapeutic and evolutive discription.

Detailed Description

Not available

Study Timeline

• Status Verified: 2025-04
• Study First Submitted: 2025-04-11
• Study First Submitted QC: 2025-04-11
• Last Update Submitted: 2025-04-11
• Study First Posted: 2025-04-18
• Last Update Posted: 2025-04-18
• Study Start: 2025-05-02
• Primary Completion: 2025-10-30
• Study Completion: 2026-10-30

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 1334

Inclusion Criteria

• Age more than 18 years
• Patients receiving health care in the departments of pulmonology, oncology, radiation oncology and thoracic surgery, whose diagnosis is confirmed histologically and/or by cytology, at least 3 months before the inclusion date
• Informed consent

Exclusion Criteria

• None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Diagnostic delay	Day 1	Delay to set the pulmonary cancer diagnosis
Survival	12 months	Overall survival
Relapse	12 months	Time to relapse

Secondary Outcome Measures

Name	Time	Method
Recommendation Compliance	Day 1	Compliance to national and international guidance of pulmonary cancer management

Trial Locations

Locations (1)

Abderrahmen Mami Hospital; 🇹🇳 Ariana, Tunisia